Researchers Create Accurate, Non-Invasive Test for Major Liver Diseases
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 14, 2022 | Diabetes & Metabolic Diseases |
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 5, 2022 | Diabetes & Metabolic Diseases |
In a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MorePosted by Andy Lundin | Jun 23, 2022 | Covid 19 |
Wearable trackers that monitor skin temperature and heart and breathing rates, combined with AI, might help pick up COVID infection earlier.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 16, 2022 | Diabetes & Metabolic Diseases |
A new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
Read More